local_hospital

Zespol Opieki Zdrowotnej W Konskich

Address
Ul. Gimnazjalna 41b, 26-200 Konskie, Poland

Zespol Opieki Zdrowotnej W Konskich

Zespol Opieki Zdrowotnej W Konskich is a clinical research center engaged in diverse therapeutic investigations spanning perioperative cardiology and neuromuscular disorders. The facility demonstrates expertise in conducting complex clinical trials that address critical medical challenges in both surgical and autoimmune disease settings.

  • Perioperative cardiac protection and prevention of myocardial injury in noncardiac surgery patients
  • Neuromuscular autoimmune disorders, particularly myasthenia gravis treatment strategies
  • Novel immunomodulatory therapies for seropositive autoimmune conditions

The center's research portfolio includes investigations of myocardial injury after noncardiac surgery (MINS) prevention through perioperative interventions in patients with atherosclerotic disease risk factors. Additionally, the facility conducts specialized trials evaluating disease-modifying treatments for myasthenia gravis, focusing on combination therapy approaches with immunosuppressive agents. This dual focus reflects the center's capacity to manage both acute perioperative care studies and chronic autoimmune disease management trials.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
2
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
2
Outperforms 43% of sites
public
Therapeutic diversity
2areas
Outperforms 53% of sites
groups
Sponsor diversity
2sponsors
Outperforms 44% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Zespol Opieki Zdrowotnej W Konskich

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Ivabradine in Preventing Myocardial Injury Post-Noncardiac Surgery in Patients with or at Risk of Atherosclerotic DiseaseUniwersytet Jagiellonski Collegium MedicumPhase IIINot RecruitingJun 2022Apr 2026

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Cladribine1Unknown2021-12-172021-12-17

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.